Publications by authors named "Neil Hounslow"

Claim this Profile
D
Drug-drug interactions between pemafibrate and statins on pharmacokinetics in healthy male volunteers: Open-label, randomized, 6-sequence, 3-period crossover studies.
Tomohiro Kamimura, Neil Hounslow, Hideki Suganami, Ryohei Tanigawa

Clin Transl Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy.
Henry N Ginsberg, Neil J Hounslow, Yusuke Senko, Hideki Suganami, Pawel Bogdanski

Diabetes Care· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia.
Peter J Meikle, Gerard Wong, Ricardo Tan, Philippe Giral, Paul Robillard, Neil Hounslow

J Lipid Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk.
Marjet J A M Braamskamp, Claudia Stefanutti, Gisle Langslet, Euridiki Drogari, Albert Wiegman, Neil Hounslow

J Pediatr· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitavastatin therapy in polymedicated patients is associated with a low risk of drug-drug interactions: analysis of real-world and phase 3 clinical trial data.
Masahiko Gosho, Masaya Tanahashi, Neil Hounslow, Tamio Teramoto

Int J Clin Pharmacol Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitavastatin Concentrations Are Not Increased by CYP3A4 Inhibitor Itraconazole in Healthy Subjects.
Shunji Nakagawa, Masahiko Gosho, Yuji Inazu, Neil Hounslow

Clin Pharmacol Drug Dev· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia.
Steen Stender, Dragos Budinski, Neil Hounslow

Eur J Prev Cardiol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia.
Steen Stender, Dragos Budinski, Masahiko Gosho, Neil Hounslow

Eur J Prev Cardiol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the pharmacokinetics of pitavastatin by formulation and ethnic group: an open-label, single-dose, two-way crossover pharmacokinetic study in healthy Caucasian and Japanese men.
Steve Warrington, Shunji Nagakawa, Neil Hounslow

Clin Drug Investig· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy of pitavastatin versus simvastatin.
Mats Eriksson, Dragos Budinski, Neil Hounslow

Adv Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial.
Mats Eriksson, Dragos Budinski, Neil Hounslow

Adv Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia.
Leiv Ose, Dragos Budinski, Neil Hounslow, Valerie Arneson

Atherosclerosis· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia.
Leiv Ose, Dragos Budinski, Neil Hounslow, Valerie Arneson

Curr Med Res Opin· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
Martin J Brodie, Elaine A Wilson, David L Wesche, Christine W Alvey, Edward J Randinitis, Neil J Hounslow

Epilepsia· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killing pain, not neurons.
Barbara G Sahagan, Diane T Stephenson, Neil Hounslow, Dane R Liston, Pamela T Manning

Nat Med· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis